235 related articles for article (PubMed ID: 33865401)
21. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
[TBL] [Abstract][Full Text] [Related]
22. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
[TBL] [Abstract][Full Text] [Related]
23. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
Blitzer GC; Glazer T; Burr A; Gustafson S; Ganz O; Meyers R; McDowell KA; Nickel KP; Mattison RJ; Weiss M; Chappell R; Rogus-Pulia NM; Galipeau J; Kimple RJ
Cytotherapy; 2023 Nov; 25(11):1139-1144. PubMed ID: 37589639
[TBL] [Abstract][Full Text] [Related]
24. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
25. Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations.
Lalla RV; Long-Simpson L; Hodges JS; Treister N; Sollecito T; Schmidt B; Patton LL; Brennan MT;
BMC Oral Health; 2017 Feb; 17(1):59. PubMed ID: 28241807
[TBL] [Abstract][Full Text] [Related]
26. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
[TBL] [Abstract][Full Text] [Related]
27. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
28. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
Heukelom J; Hamming O; Bartelink H; Hoebers F; Giralt J; Herlestam T; Verheij M; van den Brekel M; Vogel W; Slevin N; Deutsch E; Sonke JJ; Lambin P; Rasch C
BMC Cancer; 2013 Feb; 13():84. PubMed ID: 23433435
[TBL] [Abstract][Full Text] [Related]
29. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
30. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
31. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
Braaksma M; Levendag P
Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
[TBL] [Abstract][Full Text] [Related]
32. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
35. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
[TBL] [Abstract][Full Text] [Related]
36. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
37. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
38. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
[TBL] [Abstract][Full Text] [Related]
39. Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
Poon WY; Thomson M; McLoone P; Wilson C; Crosbie R; Schipani S; Grose D; James A; Lamb C; Rizwanullah M; Campbell F; Easton F; Paterson C
Clin Otolaryngol; 2020 Nov; 45(6):847-852. PubMed ID: 32501648
[TBL] [Abstract][Full Text] [Related]
40. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
